DOI: http://doi.org/10.15350/24097616.2019.4.43

Tatiana V. Skryl – Candidate of economic Sciences, Associate Professor of economic theory, Plekhanov Russian University of Economic, Moscow, Russian Federation, SPIN code: 4124-8507/ORCID: 0000-0002-3706-218, E-mail: skryl.tv@rea.ru

Abstract. The health system faces a number of economic, financial and human resource challenges. It is especially important to start working to eliminate the current gaps today, when Russian President Vladimir Putin noted the main problems of today’s health care system: reducing the availability of primary health care in the regions, the shortage of medical specialists and insufficient drug supply. This is also imposed by the investment hunger in the framework of solving the strategic tasks set by the leadership of modern Russia. The institute of public-private partnership allows to attract private sector funds to solve problems at the national level. At this stage, the author analyzed a large number of foreign and domestic studies, which are at the intersection of Economics and medicine, to find the optimal solution to the search for an investment resource for the implementation of tasks in the field of medicine. The purpose of the study: to analyze the possibility of using public-private partnership tools in the modern health care system. Research methods: modeling of various variants of interaction between the state and business in the framework of projects in the health care system. The study is based on the definition of the main elements of building a model of organization of the health care system and rehabilitation medicine on the basis of the introduction of public-private partnership mechanisms in order to increase the investment attractiveness of health care institutions. The results of the study: in the course of scientific work, reference indicators that affect the willingness of the private sector to invest in the health care system are identified. In the framework of the model, the author considered the possible risks of attracting private funds to medicine against the background of limited opportunities for budgets of all levels to Finance the unfavorable situation of many health care institutions. In conclusion, the author found that the use of public – private partnership in the public health system has many positive effects that bring benefits to both parties to the agreement. Based on the results obtained in the scientific article, the author made a number of recommendations on attracting private investment in the field of health care.

Keywords: institute, public-private partnership, health care system, restorative medicine, private investment, infrastructure.

References:

1. Acemoglu D., Johnson S., Robinson J.A. The colonial origins of comparative development: An empirical investigation. American Economic Review, 2001, no. 91 (5), pp. 1369-1401        DOI: 10.1257/aer.91.5.1369
2. Agarwal S., Perry H.B., Long L.A., Labrique A.B. Evidence on feasibility and effective use of Health strategies by frontline health workers in developing countries: Systematic review. Tropical Medicine and International Health, 2015, no. 20 (8), pp. 1003-1014. DOI: 10.1111/tmi.12525
3. Anthony M.P., Burrows J.N., Duparc S., Jmoehrle J., Wells, T.N.C. The global pipeline of new medicines for the control and elimination of malaria. Malaria Journal, 2012, no.11, DOI: 10.1186/1475-2875-11-316
4. Cherednichenko O.V. A retrospective look at the place and role of the modern industrial revolution. Economics and entrepreneurship, 2017, no. 11 (88), pp. 150-155. URL: https://elibrary.ru/item.asp?id=32407514 (In Russian)
5. Cherednichenko O.V. Digital economy in a historical coordinate system. Innovation and investment, 2018, no 3, pp. 40-44. URL: https://elibrary.ru/item.asp?id=37098968 (In Russian)
6. Crager S.E. Improving global access to new vaccines: Intellectual property, technology transfer, and regulatory pathways. American Journal of Public Health, 2014, no. 104 (11), pp. 85-91. DOI: 10.2105/AJPH.2014.302236
7. Diependaele L., Cockbain J., Sterckx S. Raising the Barriers to Access to Medicines in the Developing World – The Relentless Push for Data Exclusivity. Developing World Bioethics, 2017, no. 17 (1), pp. 11-21. DOI: 10.1111/dewb.12105
8. Gerrard M. B. What Are Public-Private Partnerships, and How Do They Differ from Privatizations? Finance & Development, 2001, Vol. 38, no. 3, p.45.
9. Gureeva E. Potential of development of ethnosport in the subjects of the Russian Federation. CITISE, 2019, no. 3 (20), p.7. URL: https://elibrary.ru/item.asp?id=39135326 (In Russian)
10. Hogerzeil H.V., Iyer J.K., Urlings L., Prasad T., Brewer, S. Is the pharmaceutical industry improving with regard to access to essential medicines? The Lancet Global Health, 2014, no. 2 (3), pp. 139-140. DOI: 10.1016/S2214-109X(13)70159-1
11. Matthew D.B., Earnest M. A Property Right to Medical Care. Journal of Legal Medicine, 2008, Vol. 29, no. 1, p. 50.
12. McNeill D., Birkbeck C.D., Fukuda-Parr S., Grover A., Schrecker T., Stuckler D. Political origins of health inequities: trade and investment agreements. The Lancet, 2017, no. 389 (10070), pp. 760-762.  DOI: 10.1016/S0140-6736(16)31013-3
13. Miller E. Flying Beneath the Radar of Health Reform: The Community Living Assistance. Services and Supports, 2011.
14. Moon S., Jambert E., Childs M., Schoen-AngererT. A. win-win solution? A critical analysis of tiered pricing to improve access to medicines in developing countries. Globalization and Health, 2011, no. 39. DOI: 10.1186/1744-8603-7-39
15. North D. Institutions, Institutional Change and Economic Performance. Cambridge, Cambridge University Publ., 1990.
16. Olins W. Branding Nation – the historical context. Journal of Brand Management, 2005, no. 5, pp. 4-5.
17. Omran A.R. The epidemiologic transition: A theory of the epidemiology of population change. Milbank Quarterly, 2005, no. 83 (4), pp. 731-757. DOI: 10.1111/j.1468-0009.2005.00398.x
18. Osipov V.S., Skryl T.V. The Strategic Directions of the Modern Russian Economic Development. International Business Management, 2016, Vol. 10, no. 6, pp. 710-717.
19. Pratt B., Loff B. Linking research to global health equity: The contribution of product development partnerships to access to medicines and research capacity building. American Journal of Public Health, 2013, no. 103 (11), pp. 1968-1978. DOI: 10.2105/AJPH.2013.301341
20. Seelman K.D., Werner R. Technology transfer of hearing aids to low and middle income countries: Policy and market factors. Disability and Rehabilitation: Assistive Technology, 2014, no. 9 (5), pp. 399-407. DOI: 10.3109/17483107.2014.905641
21. Silvestrov S.N., Zeldner A.G., Osipov V.S. Introduction to the Theory of Economic Dysfunction. Mediterranean Journal of Social Sciences, 2015, Vol. 6, no.3, pp. 394-399.
22. Sorokina N.Yu., Cherednichenko L.G., Gubarev R.V., Bondarenko N.E. Interregional social differentiation as safe socio- economical dynamics in Russia. Jiuqing Cheng Publ., 2018, pp. 418-423.
23. Stevens H., Van Overwalle G., Van Looy B., Huys, I. Intellectual property policies in early-phase research in public-private partnerships. Nature Biotechnology, 2016, no. 34 (5), pp. 504-510. DOI: 10.1038/nbt.3562
24. Stevens H., Van Overwalle G., Van Looy B., Huys I. Perspectives and opportunities for precompetitive public-private partnerships in the biomedical sector. Biotechnology Law Report, 2013, no. 32 (3), pp. 131-139. DOI: 10.1089/blr.2013.9929
25. Williams O.D., Ooms G., Hill P.S. Cautionary notes on a global tiered pricing framework for medicines. American Journal of Public Health, 2015, no. 105 (7), pp. 1290-1293. DOI: 10.2105/AJPH.2015.302554
26. Yager P., Edwards T., Fu E., Helton K., Nelson K., Tam M.R., Weigl B.H. Microfluidic diagnostic technologies for global public health, 2006, no. 442 (7101), pp. 412-418. DOI: 10.1038/nature05064

For citation:

Skryl T.V.  Public-private partnership in health care system: case study in Russia. CITISE, 2019, no. 4, pp. 459-466. DOI: http://doi.org/10.15350/24097616.2019.4.43